Payments to Acquire Property, Plant, and Equipment of Revolution Medicines, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Revolution Medicines, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Revolution Medicines, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $3,266,000, a 3.1% increase year-over-year.
  • Revolution Medicines, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $15,990,000, a 55% increase from 2024.
  • Revolution Medicines, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $10,308,000, a 33% increase from 2023.
  • Revolution Medicines, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $7,729,000, a 29% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Revolution Medicines, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $15,990,000 +$5,682,000 +55% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $10,308,000 +$2,579,000 +33% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $7,729,000 -$3,087,000 -29% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $10,816,000 +$4,288,000 +66% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $6,528,000 +$3,595,000 +123% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $2,933,000 +$344,000 +13% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $2,589,000 +$1,090,000 +73% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $1,499,000 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2021 2020 FY

Revolution Medicines, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,266,000 +$99,000 +3.1% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $3,167,000 +$1,409,000 +80% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $1,758,000 -$131,000 -6.9% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $1,889,000 -$1,690,000 -47% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $3,579,000 +$2,976,000 +494% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $603,000 +$262,000 +77% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $341,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.